Capital Fund Management (CFM)
MGNX icon

Capital Fund Management (CFM)’s MacroGenics MGNX Stock Holding History

Capital Fund Management (CFM)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,332
Closed -$202K – 1575
2015
Q2 		$202K Buy
+5,332
New +$175K ﹤0.01% 1402

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital Fund Management (CFM)'s MGNX Position: Q3 2015 in Review

Capital Fund Management (CFM) sold out of MacroGenics (MGNX) in Q3 2015, closing a stake of 5,332 shares — an estimated $202K sold.

Capital Fund Management (CFM) first reported a position in MGNX in Q2 2015 and held it in 1 quarter. The position peaked at $202K in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q3 2015.

  • Capital Fund Management (CFM) reported no remaining MacroGenics position as of Q3 2015 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 5,332 MacroGenics shares in Q3 2015, an estimated $202K.
  • Capital Fund Management (CFM) first reported a position in MacroGenics in Q2 2015 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s MacroGenics position peaked at $202K in Q2 2015.
  • 125 funds tracked by Wall St. Rank held MacroGenics as of Q3 2015.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2015, filed 27 Oct 2015.